Living with Parkinson’s disease (PD) presents a multitude of challenges, extending beyond the well-known motor symptoms like tremors, and rigidity. Increasingly, healthcare professionals recognize the significant impact of mental health, particularly anxiety, on individuals navigating this neurodegenerative condition. Approximately 500,000 Americans have been diagnosed with Parkinson’s, making it the second most common neurodegenerative disorder in the United States, and that number could be as high as one million when accounting for underdiagnosis.1 Addressing anxiety is crucial, as it can significantly diminish quality of life and complicate the management of PD itself.
The connection between Parkinson’s and anxiety is complex and multifaceted. It’s not simply a matter of emotional response to a demanding diagnosis. the disease process itself can contribute to anxious feelings. Understanding the prevalence, causes, and available treatment options for anxiety in PD is essential for both patients and their healthcare providers. Effective management requires a personalized approach, acknowledging the unique experiences and symptom profiles of each individual.
How Common is Anxiety in Parkinson’s Disease?
Anxiety is a frequent companion to Parkinson’s disease. According to the Parkinson’s Foundation, roughly 40% of people with PD will experience an anxiety disorder during their lifetime.2 a substantial 50% will experience some form of depression. A 2025 study published in Movement Disorders Clinical Practice highlights that generalized anxiety disorder and social anxiety are among the most prevalent subtypes observed in this patient population.3 Yet, diagnosing anxiety in PD can be particularly challenging.
The overlap between anxiety symptoms and those of Parkinson’s disease – such as fatigue, restlessness, insomnia, and difficulty concentrating – can produce accurate assessment difficult. Additional anxiety symptoms can include unwelcome, repetitive thoughts, a feeling of being constantly on guard, avoidance of situations due to fear, irritability, restlessness, and even physical manifestations like a racing heartbeat, dizziness, or nausea.2
What Contributes to Anxiety in Parkinson’s Disease?
Several factors can contribute to the development of anxiety in individuals with Parkinson’s. Coping with the daily management of PD symptoms is a significant source of stress. The lifestyle adjustments required, coupled with the uncertainty surrounding disease progression, can understandably lead to ongoing worry.2 Research published in npj Parkinson’s Disease in 2023 explored the lived experiences of patients, revealing that some struggled to articulate their anxiety, describing it as a nebulous sensory experience, while others directly linked it to changes in their body and mind over time.4 Some patients reported pre-existing anxiety that worsened with the progression of their PD.
Treatment for Parkinson’s itself can also play a role. Fluctuations in medication effectiveness, with symptoms returning or increasing as doses wear off, can trigger anxiety. Prolonged social isolation, stemming from the impact of PD on quality of life and ability to interact, can further exacerbate anxious feelings.2
Managing Anxiety: Treatment Options
Fortunately, a range of options are available to support patients with Parkinson’s disease manage their anxiety. If anxiety appears linked to medication timing, discussing adjustments to the medication regimen with a healthcare provider is a crucial first step.2
The Movement Disorders Clinical Practice study noted that selective serotonin reuptake inhibitors (SSRIs) are frequently prescribed for anxiety in PD patients.3 Sertraline was identified as the SSRI generally best tolerated. Duloxetine, a serotonin and noradrenaline reuptake inhibitor, has also shown promise in alleviating both anxiety and chronic pain in this population. However, the optimal prescription will depend on the specific symptoms experienced by the patient. Higher doses of buspirone demonstrated some efficacy against dyskinesia, but paradoxically increased anxiety scores in some patients.3 Type-B monoamine oxidase inhibitors, while initially developed for PD treatment, showed mixed results in addressing anxiety.
Treatment isn’t limited to medication. Some participants in the npj Parkinson’s Disease study found cognitive strategies like mindfulness, rationalization, and learning new skills helpful.4 While many were hesitant about cognitive behavioral therapy (CBT), citing concerns about personalization and therapist knowledge of PD, talk therapy remains a viable option. It can provide a safe space to address isolation, develop coping mechanisms, and gain a better understanding of their condition and emotions.2
open and ongoing communication between patient and provider is paramount. Effective anxiety management in Parkinson’s disease requires a tailored approach, recognizing the unique symptoms and disease stage of each individual. This collaborative approach allows for a more personalized treatment plan, maximizing the potential for successful symptom control.
As research continues to unravel the complex interplay between Parkinson’s disease and mental health, You can anticipate more refined and targeted interventions. Ongoing studies are exploring novel therapies and strategies to improve the quality of life for those living with PD and the anxiety that often accompanies it.
Have you or a loved one been affected by anxiety and Parkinson’s disease? Share your experiences in the comments below.
Disclaimer: This information is intended for general knowledge and informational purposes only, and does not constitute medical advice. It is essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
